DK0941110T3 - Anvendelse af keratinocyt vækstfaktor-2 - Google Patents

Anvendelse af keratinocyt vækstfaktor-2

Info

Publication number
DK0941110T3
DK0941110T3 DK97913676T DK97913676T DK0941110T3 DK 0941110 T3 DK0941110 T3 DK 0941110T3 DK 97913676 T DK97913676 T DK 97913676T DK 97913676 T DK97913676 T DK 97913676T DK 0941110 T3 DK0941110 T3 DK 0941110T3
Authority
DK
Denmark
Prior art keywords
growth factor
keratinocyte growth
kgf
pancreas
gums
Prior art date
Application number
DK97913676T
Other languages
Danish (da)
English (en)
Inventor
David L Lacey
Thomas R Ulich
Dimitry M Danilenko
Catherine L Farrell
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK0941110T3 publication Critical patent/DK0941110T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK97913676T 1996-10-15 1997-10-15 Anvendelse af keratinocyt vækstfaktor-2 DK0941110T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2849596P 1996-10-15 1996-10-15
US3225396P 1996-12-06 1996-12-06
US3345796P 1996-12-10 1996-12-10

Publications (1)

Publication Number Publication Date
DK0941110T3 true DK0941110T3 (da) 2004-06-01

Family

ID=27363283

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97913676T DK0941110T3 (da) 1996-10-15 1997-10-15 Anvendelse af keratinocyt vækstfaktor-2

Country Status (10)

Country Link
EP (1) EP0941110B1 (de)
JP (1) JP4270580B2 (de)
AT (1) ATE259651T1 (de)
AU (1) AU725509B2 (de)
CA (1) CA2268741C (de)
DE (2) DE69738336T2 (de)
DK (1) DK0941110T3 (de)
ES (2) ES2297286T3 (de)
PT (1) PT941110E (de)
WO (1) WO1998016243A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232667B2 (en) 1995-02-14 2007-06-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 polynucleotides
US6077692A (en) 1995-02-14 2000-06-20 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US6693077B1 (en) 1995-02-14 2004-02-17 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
NZ505324A (en) 1997-12-22 2002-11-26 Human Genome Sciences Inc Liquid and lyophilised KGF-2 polypeptide formulations used to accelerate soft tissue growth or regeneration
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
US6242666B1 (en) 1998-12-16 2001-06-05 The Scripps Research Institute Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
KR20020010920A (ko) * 1999-06-02 2002-02-06 추후제출 각질세포 성장 인자-2 제제
WO2001002433A1 (en) * 1999-07-02 2001-01-11 Human Genome Sciences, Inc. Keratinocyte growth factor-2
WO2001072957A2 (en) * 2000-03-31 2001-10-04 Nobuyuki Itoh Fibroblast growth factor-like molecules and uses thereof
US7202066B2 (en) * 2002-01-29 2007-04-10 Carrington Laboratories, Inc. Combination of a growth factor and a protease enzyme

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK281674B6 (sk) * 1993-03-26 2001-06-11 Amgen Inc. Farmaceutická kompozícia na stimuláciu hepatocytov, pneumocytov typu ii, pohárikovitých buniek produkujúcich mucín a iných epitelových buniek
DK0815115T3 (da) * 1995-02-14 2003-09-15 Human Genome Sciences Inc Keratinocytvækstfaktor-2
PT1486565E (pt) * 1995-10-11 2008-02-28 Novartis Vaccines & Diagnostic Combinação de pdgf, kgf, igf e igfbp para cicatrização de ferimentos
US6355862B1 (en) * 1995-10-13 2002-03-12 Purdue Research Foundation Fruit quality by inhibiting production of lipoxygenase in fruits

Also Published As

Publication number Publication date
DE69738336T2 (de) 2008-04-03
CA2268741C (en) 2007-04-24
DE69727691D1 (de) 2004-03-25
EP0941110A1 (de) 1999-09-15
ES2216134T3 (es) 2004-10-16
AU725509B2 (en) 2000-10-12
PT941110E (pt) 2004-07-30
ES2297286T3 (es) 2008-05-01
CA2268741A1 (en) 1998-04-23
JP2001506586A (ja) 2001-05-22
EP0941110B1 (de) 2004-02-18
AU5080698A (en) 1998-05-11
WO1998016243A1 (en) 1998-04-23
DE69738336D1 (de) 2008-01-10
JP4270580B2 (ja) 2009-06-03
DE69727691T2 (de) 2004-07-22
ATE259651T1 (de) 2004-03-15

Similar Documents

Publication Publication Date Title
NO953781D0 (no) Terapeutisk anvendelse av keratinocyttvekstfaktor
FR2721198B1 (fr) Prothèse implantable souple, utilisée en chirurgie pour l'augmentation de volume ou la reconstruction des tissus mous, notamment prothèse mammaire.
WO2005097219A3 (en) Ecm-based graft material
TR200201440T2 (tr) Biomedikal kullanım için radyum-223 hazırlanması
BR0210056A (pt) composições e métodos para tratamento de hiperplasia
DK1131096T3 (da) Anti-CD20-antistofbehandling af patienter, der modtager knoglemarvs- eller periferisk blodstamcelletransplantationer
DK1140016T3 (da) Præparat og kit til anvendelse ved intraoculær kirurgi
WO2004087006A3 (en) Implant delivery technologies
AU5056196A (en) Hydrogel-forming, self-solvating absorbable polyester copolymers and methods for use thereof
BR0212898A (pt) Método de tratamento de infecções do ouvido médio
DK0941110T3 (da) Anvendelse af keratinocyt vækstfaktor-2
DK1007566T3 (da) Terapeutisk anvendelse af SMR1-protein og aktive derivater deraf
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
CA2218333A1 (en) Surgical method for rejuvenating or reshaping body members by bone grafting _______________________________________________________
WO1995016435A3 (en) Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
DK0821969T3 (da) Medicinsk sammensætning omfattende TCF-II
Shields et al. Hydroxyapatite orbital implant after enucleation for intraocular tumors
Hanna Complex and redo hypospadias repairs: management of 402 patients
RU2085163C1 (ru) Способ хирургической реконструкции наружного слухового прохода при его рубцовых стриктурах и облитерациях
RU97114014A (ru) Способ предупреждения послеоперационных осложнений при имплантации искусственного хрусталика
RU2001104568A (ru) Способ ампутации конечности при облитерирующих заболеваниях артерий
SI1196159T1 (en) Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues
UA31468A (uk) Спосіб хірургічного лікування рефлюксної хвороби стравоходу
PL330260A1 (en) Intraocular implant for use in surgical treatment of glaucoma
ITMI20011185A0 (it) Protesi per l'occlusione dell'auricola cardiaca sinistra con impiantotranscatetere